A protein-language model enabled selective β-catenin degraders in preclinical tests
Source check: Source checked. Not independent scientific confirmation.
Finding: A protein-language model helped design candidate binders used in programmable degraders. Selected designs reduced abnormal β-catenin in cell experiments, and one candidate was tested in mice. These preclinical results do not establish human safety or therapeutic efficacy.
Technology: SaLT&PepPr, a protein-language-model-based algorithm, designed candidate β-catenin-binding peptides.
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- A protein-language-model-based algorithm designed candidate binders that enabled a selective-degrader study.
- Test and result
- Selected model-designed candidates were evaluated in cell experiments and a mouse study; the result is preclinical.
- Limitation / still unknown
- No human safety or therapeutic-efficacy evidence is reported.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13524019/ · https://www.biorxiv.org/content/10.1101/2024.11.10.622803v1
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary full-text review as recorded in case evidence; record-level claim and attribution review..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.